European Archives - Page 380 of 1053 - European Medical Journal

Novartis' Reshema Kemps-Polanco on drive and diversity

What drives Novartis Oncology’s Reshema Kemps-Polanco to succeed?

CT Colonography Versus Optical Colonoscopy: Cost-Effectiveness in Colorectal Cancer Screening

In 2017, colorectal cancer (CRC) accounted for 13% of new malignancy diagnoses in Canada. It is the second leading cause of cancer-related deaths in Canadian males, and the third leading cause of cancer related deaths in Canadian females.

An Unexpected Post-ocrelizumab Improvement in Glycaemic Control in a Patient with Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system, causing a plethora of neurological manifestations and a leading cause of non-traumatic disability among young adults.

5 minutes with Anat Cohen-Dayag, CEO, Compugen

Five minutes with Anat Cohen-Dayag, CEO of clinical-stage drug discovery and development company Compugen.

Is the biotech boom on thin ice?

After dizzying heights of investment during the pandemic, biotechs have observed a slump, but the future may look more promising.

The Magnificent Surgeon

Jonathan Sackier is joined by Ricky Bhogal, a Consultant at the Royal Marsden Hospital, London, UK, who specialises in Hepato-Pancreato-Biliary Oncology.

Artificially intelligent drug discovery

AI is being implemented into drug development to free up time, money and manpower, but how can humans and computers work together?

Photoprotection and the Science Behind Skin Healing

Sun exposure can lead to tanning, but also to skin damage due to the actions of ultraviolet A and B, visible light, and infrared radiation. One result of sun exposure is field cancerisation (FC), the precursor to actinic keratosis (AK), which in turn is a risk factor for, most notably, squamous cell carcinoma.

EMJ Dermatology 10.1 2022

The latest issue of EMJ Dermatology is out now and features a review of the European Academy of Dermatology and Venerology (EADV) Congress 2022.

Review of the European Academy of Dermatology and Venereology (EADV) Congress 2022

THIS YEAR, the European Academy of Dermatology and Venereology (EADV) adopted a pioneering hybrid format for its congress, allowing delegates to attend onsite in Milan, Italy, as well as online. Clinicians and academics came together with one common goal: to build an international community that develops, shares, and adopts best practices within the fields of dermatology and venereology.